|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.190 USD | +8.55% |
|
+7.16% | +22.87% |
| 01-09 | Amazon Pharmacy Begins Offering Wegovy Pill -- Update | DJ |
| 01-06 | LifeMD, Inc. Enters Enters into a Credit Agreement (the Credit Agreement) with Citizens Bank, N.A | CI |
| Capitalization | 202M 173M 161M 150M 280M 18.18B 300M 1.85B 727M 8.7B 756M 741M 31.89B | P/E ratio 2025 * |
-18.5x | P/E ratio 2026 * | -11.2x |
|---|---|---|---|---|---|
| Enterprise value | 202M 173M 161M 150M 280M 18.18B 300M 1.85B 727M 8.7B 756M 741M 31.89B | EV / Sales 2025 * |
0.85x | EV / Sales 2026 * | 0.9x |
| Free-Float |
83.76% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: LifeMD, Inc.
More recommendations
More press releases
| 1 day | +8.55% | ||
| 1 week | +7.16% | ||
| Current month | +22.87% | ||
| 1 month | +23.24% | ||
| 3 months | -32.09% | ||
| 6 months | -62.79% | ||
| Current year | +22.87% |
| 1 week | 3.84 |  | 4.36 |
| 1 month | 3.18 | | 4.36 |
| Current year | 3.38 | | 4.36 |
| 1 year | 3.18 | | 15.84 |
| 3 years | 1.14 | | 15.84 |
| 5 years | 1.14 | | 33.02 |
| 10 years | 0.42 | | 33.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shayna Dray
CEO | Chief Executive Officer | 39 | 31/07/2025 |
Marc Benathen
DFI | Director of Finance/CFO | 46 | 28/02/2021 |
Shane Biffar
CMP | Compliance Officer | 43 | 31/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Will Febbo
BRD | Director/Board Member | 57 | 19/06/2023 |
John Strawn
CHM | Chairman | 65 | - |
Roberto Simon
BRD | Director/Board Member | 51 | 05/11/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.55% | +7.16% | -11.60% | +117.10% | 186M | |
| -2.88% | +5.37% | +7.10% | +43.45% | 39.47B | |
| -0.47% | -0.75% | -16.48% | +259.84% | 14.67B | |
| -1.51% | -0.51% | -6.31% | +58.62% | 4.99B | |
| +3.12% | +50.08% | - | - | 3.35B | |
| -4.07% | +4.54% | - | - | 2.82B | |
| +2.31% | +10.76% | - | - | 2.3B | |
| +0.89% | +9.08% | +21.07% | -7.73% | 2.28B | |
| +1.49% | +29.01% | +30.72% | - | 1.51B | |
| +9.28% | +19.21% | +41.42% | -28.05% | 1.28B | |
| Average | +1.57% | +9.92% | +9.42% | +73.87% | 7.29B | |
| Weighted average by Cap. | -1.50% | +4.66% | +2.37% | +92.04% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 237M 203M 189M 176M 328M 21.34B 352M 2.17B 854M 10.21B 888M 870M 37.42B | 224M 192M 178M 166M 311M 20.19B 333M 2.06B 808M 9.66B 840M 823M 35.42B |
| Net income | -7.89M -6.76M -6.29M -5.86M -10.95M -712M -11.75M -72.42M -28.47M -340M -29.61M -29M -1.25B | -14.91M -12.77M -11.87M -11.07M -20.68M -1.34B -22.18M -137M -53.75M -643M -55.91M -54.76M -2.36B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
306
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/01/26 | 4.190 $ | +8.55% | 1,268,121 |
| 09/01/26 | 3.860 $ | -3.50% | 1,137,387 |
| 08/01/26 | 4.000 $ | +1.78% | 743,442 |
| 07/01/26 | 3.930 $ | -6.87% | 1,365,341 |
| 06/01/26 | 4.220 $ | +7.93% | 2,226,700 |
Delayed Quote Nasdaq, January 12, 2026 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
4.190USD
Average target price
9.250USD
Spread / Average Target
+120.76%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LFMD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition